THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Dose of relief

Are generic drugs just what the cost-cutters ordered? As healthcare prices spiral upward, some are encouraged by an emerging trend: Key drugs are losing patent protection. Now they look to the FDA to unclog the approval pipeline for generics.

By Diedtra Henderson
Globe Staff / April 30, 2006

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

WASHINGTON -- They're not sexy. They're not the darlings of multimillion-dollar advertising campaigns. But, generic drugs account for more than half of prescriptions written and, with the advent of the Medicare prescription drug benefit, members of Congress want to tap generics' savings potential. (Full article: 1021 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass